Skip to main contentSkip to footer

At-home hydrogen breath testing

Ending Guesswork in Gut Health

  • Diagestics takes an established biological signal – Breath Hydrogen – and aims to makes it simple, inexpensive, disposable, self-administered, immediate and repeatable around everyday food contents.
  • Diagestics is initially being developed & marketed as a low-risk consumer wellness product that measures breath hydrogen, to help users understand how foods affect their digestive fermentation patterns. it is not initially intended to diagnose or treat IBS, SIBO, lactose intolerance or offer medical conditions.
Global functional bowel disorders infographic

The opportunity

A simpler path to repeated breath testing

Current clinic-based testing can be costly, slow, and inconvenient. Diagestics is being developed as a lower-cost home alternative using disposable cartridges.

01

Home-first model

A compact reader designed for convenient use outside the clinic.

02

Single-use cartridges

Sealed cartridges designed around proprietary hydrogen sensing.

03

Recurring revenue

A reader-and-cartridge business model with recurring cartridge purchases.

Video by Dr. Farivar

The Diagestics solution

Precision gut-health testing, designed for home use

The development program combines a low-cost electronic reader with pre-packaged sensor cartridges and food substrates.

✓
Sensor prototypes fabricated and in testing
✓
Electronics design complete
✓
Preliminary device and cartridge design complete
DIAGESTICS system

Business model

Low-cost reader. Recurring cartridge revenue.

The investor deck presents a razor-and-blade model intended to reduce the initial barrier to adoption while generating recurring cartridge revenue.

DIAGESTICS reader
$20–$30

Reader Device
One-time fee · target 50% margin

Cartridge
$5–$10

Disposable Cartridge
Recurring revenue · target 80% margin

$5–$8

Consumable Packages
Recurring revenue · target 80% margin

Development roadmap

Building toward validation and market entry

The current company roadmap combines product development, pilot deployment, clinical studies, manufacturing partnerships, and regulatory planning.

Product design and testing complete
100 pilot units ready to deploy
Begin limited trials

Trials complete and manufacturing partner identified

Raising a $3M seed round

Diagestics is seeking investment to support a two-year development runway including design optimization, prototype manufacturing, testing, validation, and market preparation.

Product is under development and is not currently offered for sale. This prototype is for company and investor information only.